drugset / Trial / NCT00335101

Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography

NCT00335101 ↗

Phase 4 Withdrawn GE Healthcare
RandomizedParallel-groupDouble-blindDiagnostic

Summary

The study is to evaluate and compare the effects on kidney function of three iodinated contrast media (CM) in patients at risk of kidney damage evaluating serum creatinine (Scr) concentrations up to three days after CM administration.

Timeline

Start
2006-06
Primary completion
—
Completion
—

Outcome

Outcome not reported

Stopped (Business): “Sponsor Decision to withdraw study (comparative product withdrawn from the market)”

Drugs

EvaluationDrugModalityDoseRoute
Subject Iodixanol Diagnostic / imaging agent — —
Subject Iopromide Diagnostic / imaging agent — —
Subject Ioversol Small molecule — —